The logo of InnoCare Pharma Limited. [Photo/VCG] InnoCare Pharma Limited, a Hong Kong-listed Chinese biopharma company, said that at least five of the company’s innovative drug products are expected to get approved and enter the market in three to four years. Also, up to four of such new drug products will enter the international market, … Continue reading InnoCare Pharma Limited expects multiple drug products to reach approval